2021 May 28;11(5):e047993
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
This is a human recombinant, single, non-glycosylated, polypeptide chain containing 83 amino acids and having a molecular mass of 9200 Daltons
Spontaneous reporting systems alone cannot definitively determine whether a medication causes a specific adverse event
Against this backdrop, orforglipron, a novel oral, non-peptide GLP-1 receptor agonist developed by Eli Lilly, has emerged as one of the most closely watched candidates in metabolic disease therapy
Clinically, we have observed it rapidly resolve severe tinnitus (ringing in the ears) and alleviate early cognitive decline and peripheral neuropathy